(Published July 2013)
1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38(2):90-6.
2. Guttmacher Institute. Facts on induced abortion in the United States [fact sheet]. May 2011. Available at http://www.guttmacher.org/pubs/fb_induced_abortion.pdf. Accessed June 1, 2012.
3. Nelson AL, Cwiak, C. Combined Oral Contraceptives. In: Hatcher Trussell J, Nelson AL, Cates W Jr, et al, eds. Contraceptive Technology. 20th revised edition. New York, NY: Ardent Media, 2011, pp 249-251.
4. Secura GM, Allsworth JE, Madden T, et al. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol. 2010;203(2):115.e1-7.
5. Mestad R, Secura G, Allsworth JE, et al. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception. 2011;84:493-8.
6. Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117(5):1105-13.
7. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397-404.
8. Guttmacher Institute. Improving contraceptive use in the United States. In Brief. 2008 Series, No. 1, April 2008.
9. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol. 2010;116(6):1302-9.
10. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR . 2010;59(RR-04):1-86.
11. Lamvu G, Steiner MJ, Condon S, et al. Consistency between most important reasons for using contraception and current method used: the influence of health care providers. Contraception. 2006;63(4):399-403.
12. Association of Reproductive Health Professionals. Breaking the Contraceptive Barrier: Techniques for Effective Contraceptive Consultations. Clinical Proceedings. October 2008. Available at www.arhp.org/Publications-and-Resources/Clinical-Proceedings/Breaking-the-Contraceptive-Barrier. Accessed May 15, 2012.
13. Griffin T, Tooher R, Nowakowski K, et al. How little is enough? The evidence for post-vasectomy testing. J Urol. 2005;174(1):29-36.
14. Kumar V, Kaza RM, Singh I, et al. An evaluation of the no-scalpel vasectomy technique. BJU Int. 1999;83:283-4.
15. Hillis SD, Marchbanks PA, Tylor LR, Perterson HB, for the US Collaborative Review of Sterilization Working Group. Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol. 1999; 93:889–95.
16. What is Essure? Accessed May 15, 2012.
17. Connor VF. Essure: a review six years later. J Minim Invasive Gynecol. 2009;16(3):282-90.
18. Revisiting Your Women’s Health Care Visit. Harris Interactive for the Association of Reproductive Health Professionals. Conducted June 30–July 14, 2004.
19. Sivin I. Utility and drawbacks of continuous use of a Copper T IUD for 20 years. Contraception. 2007;75:S70-5.
20. Alvarez F, Brache V, Fernandez E, et al. New insights on the mode of action of intrauterine contraceptive devices in women. Fertil Steril. 1988;49(5):768-73.
21. Wu S, Godfrey EM, Wojdyla D, et al. T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG. 2010;117(10):1205-10.
22. Dean G, Schwarz EB. Intrauterine contraception. In: Hatcher RA, Trussell J, Nelson AL, Cates W Jr, et al, eds. Contraceptive Technology. 20th revised edition. New York, NY: Ardent Media, 2011, pp 147-91.
23. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet. 2000;356(9234):1013-9.
24. World Health Organization. Selected practice recommendations. Department of Reproductive Health and Research, Family and Community Health Cluster. Geneva: WHO, 2004.
25. Milsom I, Andersson K, Jonasson K, et al. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status. Contraception. 1995;52:175–9.
26. Milsom I, Rybo G, Lindstedt G. The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. Contraception. 1990;41(3):271-81.
27. Larsson G, Milsom I, Jonasson K, et al. The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. Contraception. 1993;48(5):471-80.
28. Planned Parenthood Federation of America. Diaphragm. Available at http://www.plannedparenthood.org/health-topics/birth-control/diaphragm-4244.htm. Accessed May 15, 2012.
29. Fihn SD, Latham RH, Roberts P, et al. Association between diaphragm use and urinary tract infection. JAMA. 1985;254(2):240-5.
30. US Food and Drug Association. Medical devices: FemCap. Available at www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm082597.htm. Accessed May 15, 2012.
31. d’Oro LC, Parazzini F, Naldi L, et al. Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review. Genitourin Med. 1994;70(6):410-7.
32. Mauck CK, Weiner DH, Creinin MD, et al. FemCap with removal strap: ease of removal, safety and acceptability. Contraception. 2006;73(1):59-64.
33. Van Damme L, Ramjee G, Alary M, et al.; COL-1492 Study Group. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360:971-7.
34. Trussell J, Sturgen K, Strickler J, et al. Comparative contraceptive efficacy of the female condom and other barrier methods. Fam Plann Perspect. 1994;26:66-72.
35. Jones RK, Fennel J, Higgins JA, et al. Better than nothing or savvy risk-reduction practice? The importance of withdrawal. Contraception. 2009;79:407-10.
36. Zuckerman Z, Weiss DB, Orvieto R. Does preejaculatory penile secretion originating from Cowper’s gland contain sperm? J Assist Reprod Genet. 2003;20:157-9.
37. The rules of the Billings Ovulation Method™. Accessed May 14, 2012.
38. Jennings VH, Arevalo M. Fertility awareness-based methods. In: Hatcher RA, Trussell J, Nelson AL, Cates W Jr, et al, eds. Contraceptive Technology. 20th revised edition. New York, NY: Ardent Media, 2011, pp 417-34.
39. Creighton Model FertilityCare™ System. What is the CrMS? Available at http://www.fertilitycare.org/creighton-model/. Accessed May 14, 2012.
40. Sinai I, Lundgren R, Arévalo M, Jennings V. Fertility awareness-based methods of family planning: predictors of correct use. Int Fam Plan Perspect. 2006;32(2):94-100.
41. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS. 1993;4(3):165-70.